FDA Finds Impurity In Suspect Heparin Batches
In a press conference Wednesday, the U.S. Food and Drug Administration identified the contaminant as oversulfated chondroitin sulfate, a chemically altered form of chondroitin sulfate.
Tests on heparin batches originating from China have shown that the contaminant accounts for as much as 50% of the active ingredient.
While chondroitin sulfate is naturally...
To view the full article, register now.